Dashboard
Manage Tickers

DMAC


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 12:09:47

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

hc-wainwright--co-reiterates-buy-on-diamedica-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on DiaM...
08/15/2025 11:11:34

HC Wainwright & Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and maintains $1...

diamedica-therapeutics-enters-sales-agreement-with-td-securities-may-sell-common-shares-up-to-100m
DiaMedica Therapeutics Enters Sales Agreem...
08/12/2025 21:37:38

-SEC Filing

diamedica-therapeutics-q2-eps-018-beats-019-estimate
DiaMedica Therapeutics Q2 EPS $(0.18) Beat...
08/12/2025 20:15:57

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

exploring-diamedica-therapeuticss-earnings-expectations
Exploring DiaMedica Therapeutics's Earning...
08/11/2025 19:02:56

craig-hallum-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-11
Craig-Hallum Maintains Buy on DiaMedica Th...
07/18/2025 15:57:35

Craig-Hallum analyst Chase Knickerbocker maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price targ...

lake-street-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-14
Lake Street Maintains Buy on DiaMedica The...
07/18/2025 15:48:28

Lake Street analyst Thomas Flaten maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price target from...

hc-wainwright--co-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on DiaMe...
07/18/2025 10:51:16

HC Wainwright & Co. analyst Matthew Caufield maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the pr...

diamedica-therapeutics-announces-interim-results-from-part-1a-of-phase-2-study-of-dm199-for-treatment-of-preeclampsia
DiaMedica Therapeutics Announces Interim R...
07/17/2025 12:20:31

Conference Call Today July 17, 2025 at 4:30 PM Eastern Time / 3:30 PM Central TimeDM199 Demonstrated Highly Statistically Signi...

hc-wainwright--co-reiterates-buy-on-diamedica-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on DiaM...
05/29/2025 11:34:43

HC Wainwright & Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and maintains $1...

diamedica-therapeutics-announces-key-opinion-leader-webinar-on-dm199-for-the-treatment-of-preeclampsia-on-wednesday-may-28-2025-at-800-am-et
DiaMedica Therapeutics Announces Key Opini...
05/19/2025 13:06:05

Company to Host Preeclampsia Key Opinion Leader Event May 28, 2025 at 8 AM Eastern / 7 AM CentralDiaMedica Therapeutics Inc. (N...

diamedica-therapeutics-q1-eps-018-inline
DiaMedica Therapeutics Q1 EPS $(0.18), Inline
05/13/2025 20:30:52

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. T...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

insights-ahead-diamedica-therapeuticss-quarterly-earnings
Insights Ahead: DiaMedica Therapeutics's Q...
05/12/2025 20:09:32

why-ericsson-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket
Why Ericsson Shares Are Trading Higher By ...
04/15/2025 09:19:09

hc-wainwright--co-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-10
HC Wainwright & Co. Maintains Buy on DiaMe...
03/19/2025 10:45:25

HC Wainwright & Co. analyst Matthew Caufield maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the pr...

diamedica-therapeutics-fy-2024-gaap-eps-060-misses-059-estimate
DiaMedica Therapeutics FY 2024 GAAP EPS $(...
03/17/2025 20:31:02

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate...

earnings-scheduled-for-march-17-2025
Earnings Scheduled For March 17, 2025
03/17/2025 08:32:11

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION